Cargando…
Challenges of Systemic Therapy Investigations for Bone Sarcomas
Bone sarcoma is a rare component of malignant solid tumors that accounts for only ~0.2% of malignancies. Bone sarcomas present various histological types, and genomic mutations differ markedly by the histological types. Although there are vast mutations in various bone sarcomas, most of them are non...
Autor principal: | Nakano, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998654/ https://www.ncbi.nlm.nih.gov/pubmed/35408900 http://dx.doi.org/10.3390/ijms23073540 |
Ejemplares similares
-
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018) -
Targeted Therapies in Sarcomas: Challenging the Challenge
por: Martín Liberal, Juan, et al.
Publicado: (2012) -
Translocation-Related Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018) -
Precision Medicine in Soft Tissue Sarcoma Treatment
por: Nakano, Kenji, et al.
Publicado: (2020) -
Bone Sarcomas: From Biology to Targeted Therapies
por: Gaspar, Nathalie, et al.
Publicado: (2012)